| | |
ASPsiRNA information |
siRNA Id: | aspsirna1972
|
siRNA Name: | siRNA-5
|
Mismatch information |
Wild siRNA (As strand 3'->5'): | GGUUUCCCACUCGCACCAU
|
ASP-siRNA (As strand 3'->5'): | GGUUUCCCACUCGCACCAG
|
Mismatch position in siRNA: | G1U |
Gene Information |
Gene Name | Collagen type VI alpha 3 (COL6A3) |
Target Sequence (5'->3'): | UCGGCAGCAUCGGGCCAAAGGGUAUUC
|
Wild allele (5'->3'): | CCAAAGGGUGAGCGUGGUA
|
Mutant allele (5'->3'): | CCAAAGGGUGAGCGUGGUA
|
Position of siRNA on target gene: | 4601-4627
|
Respective Gene/Protein Resources |
GenBank Accession: | NM_057166.4 |
Cytogenic location: | 2q37.3 |
Chromosomal coordinates: | 2:238,232,654-238,322,849 |
UniProt ID: | P12111 |
HUGO ID: | 2213 |
Reference SNp(RefSNP): | NA |
Disease/Mutation information |
Target Mutation: | (IVS16DS plus 1G-A) in intron 16
|
Matation type/variant: | Single nucleotide variant
|
Mutation at gene level: | NA
|
Pathogenic status of mutation: | Pathogenic
|
Disease: | Congenital muscular dystrophy type Ullrich (UCMD) |
Clinical Resources |
ClinVar ID: | 17152 |
KEGG disease ID: | H01341 |
OMIM ID: | 254090 |
COSMIC: | COL6A3 |
DECIPHER: | COL6A3 |
GeneTests: | COL6A3 |
ASP siRNA details |
Mutant allele (5'->3'): | CCAAAGGGUGAGCGUGGUA
|
ASP-siRNA (As strand 3'->5'): | GGUUUCCCACUCGCACCAG
|
Percentage efficacy of ASP-siRNA for mutant allele: | 65
|
Wild allele (5'->3'): | CCAAAGGGUGAGCGUGGUA
|
ASP-siRNA (As strand 3'->5'): | GGUUUCCCACUCGCACCAG
|
Percentage efficacy of ASP-siRNA for wild allele: | 35
|
Relative difference: | 30
|
Wild siRNA details |
Wild allele (5'->3'): | CCAAAGGGUGAGCGUGGUA
|
Wild siRNA (As strand 3'->5'): | GGUUUCCCACUCGCACCAU
|
Percentage efficacy of wild siRNA for wild allele: | 75
|
Wild allele (5'->3'): | CCAAAGGGUGAGCGUGGUA
|
ASP-siRNA (As strand 3'->5'): | GGUUUCCCACUCGCACCAG
|
Percentage efficacy of Wild sirna for mutant allele: | 90
|
Relative difference : | -15
|
General information |
Mismatch incorporated in siRNA/Target: | siRNA |
Cell-line used: | HEK293 |
Experimental technique used: | Dual luciferase reporter assay |
Transfection method: | Lipofectamine 2000 |
siRNA expression method: | Invitrogen |
Post-transfection duration: | 48-72 hours |
Concentration used: | 5nM |
Reference: | 24518369 |
Delivery method: | Transfection |
'Article title: | siRNA-mediated Allele-specific Silencing of a COL6A3 Mutation in a Cellular Model of Dominant Ullrich Muscular Dystrophy. |
'Authors: | Bolduc V, Zou Y, Ko D, Bönnemann CG. |
'Journal Reference: | Mol Ther Nucleic Acids. 2014 Feb 11;3:e147. doi: 10.1038/mtna.2013.74 |
'